Winners of the 2015 Reaxys PhD Prize Announced

Three chemistry researchers are recognized for innovative and original research

Hong Kong, September 9, 2015

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the three winners of the 2015 Reaxys PhD Prize at the annual Symposium held at The Chinese University of Hong Kong.

Celebrating top research conducted by leading young chemists across the globe, the Reaxys PhD Prize recognizes innovative and original research in chemistry, with an emphasis on synthesis. The Reaxys PhD Prize is the world’s most prestigious award for young chemists, with over 2500 submissions from around the world in its six year history.

The 2015 Reaxys PhD Prize winners are:

-       Andrew Jupp from the Goicoechea group, University of Oxford.

-       John Tellis from the Molander group, University of Pennsylvania.

-       Shinnosuke Uno from the Urano group, University of Tokyo.

The three winners were selected from a group of nine top finalists, who each gave a 15 minute oral presentation describing the essence of their research. These oral presentations enabled the finalists to display one of the other great skills any researcher requires: the ability to succinctly describe their work. The presentations were judged by members of the Reaxys Advisory Board and Chairs of the Reaxys PhD Prize review board.

The judges deliberated at length. The presentations were all of the highest quality. They were challenged to discuss the key aspects of their research in a crisp yet critical manner; each of the candidates prepared very thoroughly. The three winners each receive a cheque for $2000 and they will join a list of illustrious previous winners in the Reaxys Prize Club.

“We were hugely impressed with the quality of the presentations,” said Prof Eiichi Nakamura, University of Tokyo, and one of the judges. “The science presented was of a very high standard, a lot of time and effort was put into effectively communicating their research. We discussed each presentation in depth looking at the novelty of their research, the impact we imagined the research will have, and their communication skills. This was not an easy decision, each candidate had merit. However in the end we all agreed that these three winners were the best overall combining all aspects of the Reaxys PhD Prize criteria and their presentations.”

“I am delighted to welcome this year’s winners and finalists to the Reaxys Prize Club,” said David Evans PhD, Scientific Affairs Director at Reed Elsevier Properties SA. “Each year Prize Symposium winners and finalists gather with the opportunity to build new friendships, discuss research and seed the basis of a new network of innovative chemists. We created the Reaxys Prize Club in order to foster collaboration, and for participants to engage, creating a fabulous hub of bright young scientists from all disciplines of chemistry. We hope in a way to help crystalize some early relationships which will develop overtime into long lasting fruitful collaborations.”

The Chairs of the 2015 Reaxys PhD Prize's review board are Professors Tony Barrett (Imperial College London, UK), Eiichi Nakamura (University of Tokyo, Japan), Gerard Parkin (Columbia University, USA), Martin Jansen (Max-Planck Institute, Stuttgart, Germany), Barry Trost (Stanford University, USA) and Henry Wong (The Chinese University Hong Kong, Hong Kong).

For more information on this year’s winners please visit

For more information about the 2016 Reaxys PhD Prize, visit


About Reaxys
Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. For more information about Reaxys, visit

Reaxys is a trade mark of Reed Elsevier Properties SA, used under license.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Media contact
Christopher Capot
Director, Corporate Relations
+1 917 704 5174